𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Selective modulation of ER-β by estradiol and xenoestrogens in human breast cancer cell lines

✍ Scribed by V. Cappelletti; G. Saturno; P. Miodini; W. Körner; M. G. Daidone

Publisher
Springer
Year
2003
Tongue
English
Weight
264 KB
Volume
60
Category
Article
ISSN
1420-682X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGF modulation of the ras-related rhoB g
EGF modulation of the ras-related rhoB gene expression in human breast-cancer cell lines
✍ Patricia De Cremoux; Christiane Gauville; Violaine Closson; Gustavo Linares; Fab 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 996 KB

MATERIAL AND METHODS ## Cell culture Out of 10 human breast-carcinoma cell lines studied, 6 were derived from metastatic carcinoma as follows: MCF7, T47D, ZR 75-1, SKBR3

Roscovitine, a selective CDK inhibitor,
Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells
✍ Józefa Węsierska-Gądek; David Gritsch; Nora Zulehner; Oxana Komina; Margarita Ma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB

## Abstract Roscovitine (ROSC), a selective cyclin‐dependent kinase (CDK) inhibitor, arrests human estrogen receptor‐α (ER‐α) positive MCF‐7 breast cancer cells in the G~2~ phase of the cell cycle and concomitantly induces apoptosis __via__ a p53‐dependent pathway. The effect of ROSC is markedly di